Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Reliability and validity of self- and other-ratings of symptoms of ADHD in adults.

Van Voorhees EE, Hardy KK, Kollins SH.

J Atten Disord. 2011 Apr;15(3):224-34. doi: 10.1177/1087054709356163. Epub 2010 Apr 27.

2.

German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensitivity and specificity.

Christiansen H, Kis B, Hirsch O, Matthies S, Hebebrand J, Uekermann J, Abdel-Hamid M, Kraemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, Rösler M, Jacob C, Jans T, Huss M, Schimmelmann BG, Philipsen A.

Eur Psychiatry. 2012 Jul;27(5):321-8. doi: 10.1016/j.eurpsy.2010.12.010. Epub 2011 Mar 9.

PMID:
21392946
3.

Determining the Accuracy of Self-Report Versus Informant-Report Using the Conners' Adult ADHD Rating Scale.

Alexander L, Liljequist L.

J Atten Disord. 2016 Apr;20(4):346-52. doi: 10.1177/1087054713478652. Epub 2013 Mar 15.

PMID:
23503811
4.

The conners' adult ADHD rating scales--short self-report and observer forms: psychometric properties of the Catalan version.

Amador-Campos JA, Gómez-Benito J, Ramos-Quiroga JA.

J Atten Disord. 2014 Nov;18(8):671-9. doi: 10.1177/1087054712446831. Epub 2012 Jul 6.

PMID:
22771453
5.

The reliability and validity of self- and investigator ratings of ADHD in adults.

Adler LA, Faraone SV, Spencer TJ, Michelson D, Reimherr FW, Glatt SJ, Marchant BK, Biederman J.

J Atten Disord. 2008 May;11(6):711-9. Epub 2007 Nov 19.

PMID:
18025250
6.
7.

Factor structure of the Conners Adult ADHD Rating Scale (CAARS) for substance users.

Cleland C, Magura S, Foote J, Rosenblum A, Kosanke N.

Addict Behav. 2006 Jul;31(7):1277-82. Epub 2005 Oct 5.

PMID:
16169157
8.

Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).

Rösler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256 Suppl 1:i3-11. Review. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2008 Apr;258(3):192-3.

PMID:
16977549
9.

Detecting attention-deficit/hyperactivity disorder (ADHD) in adults with intellectual disability The use of Conners' Adult ADHD Rating Scales (CAARS).

La Malfa G, Lassi S, Bertelli M, Pallanti S, Albertini G.

Res Dev Disabil. 2008 Mar-Apr;29(2):158-64. Epub 2007 Apr 9.

PMID:
17416484
10.

Specificity of the CAARS in Discriminating ADHD Symptoms in Adults From Other Axis I Symptoms.

Stewart A, Liljequist L.

J Atten Disord. 2015 Dec;19(12):1007-12. doi: 10.1177/1087054712460086. Epub 2012 Oct 16.

PMID:
23074300
11.

German validation of the Conners Adult ADHD Rating Scales-self-report (CAARS-S) I: factor structure and normative data.

Christiansen H, Kis B, Hirsch O, Philipsen A, Henneck M, Panczuk A, Pietrowsky R, Hebebrand J, Schimmelmann BG.

Eur Psychiatry. 2011 Mar;26(2):100-7. doi: 10.1016/j.eurpsy.2009.12.024. Epub 2010 Jul 8.

PMID:
20619613
12.
13.

Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.

Antshel KM, Kaul P, Biederman J, Spencer TJ, Hier BO, Hendricks K, Faraone SV.

J Clin Psychiatry. 2013 Mar;74(3):e197-204. doi: 10.4088/JCP.12m07698.

PMID:
23561240
14.

Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale.

Marchant BK, Reimherr FW, Robison D, Robison RJ, Wender PH.

Psychol Assess. 2013 Sep;25(3):942-50. doi: 10.1037/a0032797. Epub 2013 May 6.

PMID:
23647041
15.
16.

Quantitative and subjective behavioural aspects in the assessment of attention-deficit hyperactivity disorder (ADHD) in adults.

Söderström S, Pettersson R, Nilsson KW.

Nord J Psychiatry. 2014 Jan;68(1):30-7. doi: 10.3109/08039488.2012.762940. Epub 2013 Mar 26.

PMID:
23527787
17.

Evaluation of Neuropsychiatric Function in Phenylketonuria: Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Subscale in Phenylketonuria.

Wyrwich KW, Auguste P, Yu R, Zhang C, Dewees B, Winslow B, Yu S, Merilainen M, Prasad S.

Value Health. 2015 Jun;18(4):404-12. doi: 10.1016/j.jval.2015.01.008. Epub 2015 Apr 4.

18.

Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis.

Robison RJ, Reimherr FW, Marchant BK, Faraone SV, Adler LA, West SA.

J Clin Psychiatry. 2008 Feb;69(2):213-21.

PMID:
18211131
19.

The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders.

Dakwar E, Mahony A, Pavlicova M, Glass A, Brooks D, Mariani JJ, Grabowski J, Levin FR.

J Clin Psychiatry. 2012 Nov;73(11):e1372-8. doi: 10.4088/JCP.12m07895.

20.

Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.

Durell TM, Adler LA, Williams DW, Deldar A, McGough JJ, Glaser PE, Rubin RL, Pigott TA, Sarkis EH, Fox BK.

J Clin Psychopharmacol. 2013 Feb;33(1):45-54. doi: 10.1097/JCP.0b013e31827d8a23. Erratum in: J Clin Psychopharmacol. 2014 Aug;34(4):542-3.

PMID:
23277268

Supplemental Content

Support Center